GeneDx Holdings Corp.
WGS
$85.74
-$5.87-6.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.53M | 5.44M | -8.31M | -29.17M | -20.24M |
| Total Depreciation and Amortization | 5.68M | 4.66M | 5.93M | 5.22M | 5.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.68M | -5.52M | 3.74M | 23.00M | 6.26M |
| Change in Net Operating Assets | 3.35M | -7.76M | -5.75M | -3.55M | -7.68M |
| Cash from Operations | 10.18M | -3.18M | -4.40M | -4.51M | -16.41M |
| Capital Expenditure | -6.13M | -3.05M | -646.00K | -1.35M | -443.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.28M | 2.53M | -7.11M | -21.35M | 1.29M |
| Cash from Investing | -9.41M | -519.00K | -7.76M | -22.70M | 843.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -911.00K | -1.53M | -707.00K | -528.00K | -462.00K |
| Issuance of Common Stock | 14.63M | 32.55M | 14.68M | 137.00K | 24.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.72M | 31.02M | 13.97M | -391.00K | -438.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.49M | 27.32M | 1.82M | -27.60M | -16.01M |